BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Liu Q, Ni W, Li Z, Bai C, Tan D, Pu C, Zhou D, Tian Q, Luo N, Tan K, Dai L, Yan Y, Pei Y, Li X, Xiao Z, Zhu H. Resolution and evaluation of 3-chlorophenyl-3-hydroxypropionylhydroxamic acid as antivirulence agent with excellent eradication efficacy in Helicobacter pylori infected mice. European Journal of Pharmaceutical Sciences 2018;121:293-300. [DOI: 10.1016/j.ejps.2018.05.029] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
Number Citing Articles
1 Liu ML, Li WY, Fang HL, Ye YX, Li SY, Song WQ, Xiao ZP, Ouyang H, Zhu HL. Synthesis and Biological Evaluation of Dithiobisacetamides as Novel Urease Inhibitors. ChemMedChem 2021. [PMID: 34687265 DOI: 10.1002/cmdc.202100618] [Reference Citation Analysis]
2 Liu Q, Shi W, Ren S, Ni W, Li W, Chen H, Liu P, Yuan J, He X, Liu J, Cao P, Yang P, Xiao Z, Zhu H. Arylamino containing hydroxamic acids as potent urease inhibitors for the treatment of Helicobacter pylori infection. European Journal of Medicinal Chemistry 2018;156:126-36. [DOI: 10.1016/j.ejmech.2018.06.065] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
3 Li WY, Ni WW, Ye YX, Fang HL, Pan XM, He JL, Zhou TL, Yi J, Liu SS, Zhou M, Xiao ZP, Zhu HL. N-monoarylacetothioureas as potent urease inhibitors: synthesis, SAR, and biological evaluation. J Enzyme Inhib Med Chem 2020;35:404-13. [PMID: 31880473 DOI: 10.1080/14756366.2019.1706503] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 3.5] [Reference Citation Analysis]
4 Ni WW, Fang HL, Ye YX, Li WY, Yuan CP, Li DD, Mao SJ, Li SE, Zhu QH, Ouyang H, Xiao ZP, Zhu HL. N-monosubstituted thiosemicarbazide as novel Ure inhibitors: synthesis, biological evaluation and molecular docking. Future Med Chem 2020;12:1633-45. [PMID: 32892642 DOI: 10.4155/fmc-2020-0048] [Cited by in F6Publishing: 1] [Reference Citation Analysis]